Nasdaq
RADX
Radiopharm Theranostics Limited
- Health Care
- Australia
- 1 day
- +0.4%
- 1 month
- −34.2%
- 1 year
- −44.7%
$2.79 · Mkt cap $40.1M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Radiopharm Theranostics Limited
$2.79 · Mkt cap $40.1M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Radiopharm Theranostics Limited trades under the ticker RADX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $40.1M. The last closing price was $2.79, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −44.7%, and −34.2% over the past month. Returns are price returns and exclude dividends.
This page exists because RADX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.